Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment

B

Bulent Ecevit University

Status

Completed

Conditions

Periodontal Disease

Treatments

Procedure: Non-surgical periodontal treatment

Study type

Observational

Funder types

Other

Identifiers

NCT02750956
Endocan

Details and patient eligibility

About

The primer aim of the study was to determine serum and gingival crevicular fluid (GCF) endocan levels in periodontal diseases pathogenesis supported with vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) levels.

Full description

The study consist of three groups: periodontally healthy individuals (group 1; n = 20), individuals with generalized chronic periodontitis (group 2; n = 20), the same patients with chronic periodontitis after they had been treated with scaling and root planing (SRP) were considered as Group 3. Clinical measurements were recorded; GCF and serum samples were obtained from each participant before and 6 weeks after therapy. Endocan, VEGF-A and TNF-α levels were measured by enzyme-linked immunosorbent assay.

Enrollment

40 patients

Sex

All

Ages

25 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Group 1 Inclusion Criteria:

  • No bone and attachment loss,
  • GI=0, PPD≤3mm, CAL≤3mm
  • Systematically healthy patients

Group 2 Inclusion Criteria:

  • GI>1, PPD≥5mm, CAL≥5mm with alveolar bone loss radiographically.
  • Systematically healthy patients

Exclusion Criteria:

  • Aggressive Periodontitis,
  • Oral pathologies,
  • Patients with any other systemic diseases,
  • Pregnant women and those in the lactation period,
  • Patients with smoking habit and taking medication
  • Patients received periodontal therapy in last 6 months

Trial design

40 participants in 3 patient groups

Group 1
Description:
Periodontal healthy individuals
Group 2
Description:
Patients with chronic periodontitis
Treatment:
Procedure: Non-surgical periodontal treatment
Group 3
Description:
the same patients in group 2 after they had been treated with scaling and root planing (SRP) were considered as Group 3.
Treatment:
Procedure: Non-surgical periodontal treatment

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems